A brain DNA co‐methylation network analysis of psychosis in Alzheimer's disease
Authors:
Open Access
- 12 February 2025
- journal article
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (2) , e14501
Abstract
INTRODUCTION: The presence of psychosis in Alzheimer's disease (AD) is suggested to be associated with distinct molecular and neuropathological profiles in the brain. METHODS: We assessed brain DNA methylation in AD donors with psychosis (AD+P) and without psychosis (AD−P) using the EPIC array. Weighted gene correlation network analysis identified modules of co‐methylated genes in a discovery cohort (PITT‐ADRC: N = 113 AD+P, N = 40 AD−P), with validation in an independent cohort (BDR: N = 79 AD+P, N = 117 AD−P), with Gene Ontology and cell‐type enrichment analysis. Genetic data were integrated to identify methylation quantitative trait loci (mQTLs), which were co‐localized with GWAS for related traits. RESULTS: We replicated one AD+P associated module, which was enriched for synaptic pathways and in excitatory and inhibitory neurons. mQTLs in this module co‐localized with variants associated with schizophrenia and educational attainment. DISCUSSION: This represents the largest epigenetic study of AD+P to date, identifying pleiotropic relationships between AD+P and related traits. Highlights: DNA methylation was assessed in the prefrontal cortex in subjects with AD+P and AD−P. WGCNA identified six modules of co‐methylated loci associated with AD+P in a discovery cohort. One of the modules was replicated in an independent cohort. This module was enriched for synaptic genes and in excitatory and inhibitory neurons. mQTLs mapping to genes in the module co‐localized with GWAS loci for schizophrenia and educational attainment.Keywords
Funding Information
- National Institute for Health and Care Research
- National Institute on Aging
- National Institutes of Health (R01AG067015)
- National Institutes of Health (P30AG066468)
- National Institutes of Health (R01AG027224)
- National Institute of Mental Health (MH116046)
- National Center for Advancing Translational Sciences (UM1TR004407)
This publication has 87 references indexed in Scilit:
- Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer's disease in the EMIF‐AD studyAlzheimer's & Dementia, 2024
- Blood‐based multivariate methylation risk score for cognitive impairment and dementiaAlzheimer's & Dementia, 2024
- Implications of Adverse Outcomes Associated with Antipsychotics in Older Patients with Dementia: A 2011–2022 UpdateDrugs & Aging, 2022
- The neural signatures of psychoses in Alzheimer’s disease: a neuroimaging genetics approachEuropean Archives of Psychiatry and Clinical Neuroscience, 2022
- Psychosis in Alzheimer’s DiseaseBiological Psychiatry, 2014
- Management of a twenty-first century brain bank: experience in the BrainNet Europe consortiumActa Neuropathologica, 2008
- Point and 5‐year period prevalence of neuropsychiatric symptoms in dementia: the Cache County StudyInternational Journal of Geriatric Psychiatry, 2007
- Increased familial risk and genomewide significant linkage for Alzheimer's disease with psychosisAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2007
- Delusions and Hallucinations Are Associated With Worse Outcome in Alzheimer DiseaseArchives of Neurology, 2005
- A short‐term inpatient program for agitated demented nursing home residentsInternational Journal of Geriatric Psychiatry, 2001